Series A
$27.2 million$0.85 per preferred share
May 2016. 32,058,817 shares issued; later repurchases are separate.
AI & semiconductors · CBRS
Cerebras Systems
Cerebras has a documented preferred-share financing history from Series A through H, followed by its May 2026 IPO. The original issue prices and offering price support a detailed pre-IPO worksheet.
01 / YOUR SCENARIO
Choose your starting point.
Starting price: $0.85 · May 2016 · issuance period
1 CBRS share equivalents per starting share at your ending date.
DOCUMENTED PRIVATE PRICE → IPO OFFER PRICE
Cerebras SystemsCBRS · Series A
Hypothetical price-only value of $1,000.00
$217,647.06May 2016 · issuance period → 2026-05-15
217.647×Price multiple
$216,647.06Gain / loss
1176.47058824 CBRS share equivalents · ending price $185
Preferred shares convert 1:1 into common shares. Original issue-price precision is retained. Multiple closing dates are represented by the stated issuance period; no specific personal purchase date is assumed.
Formula: amount ÷ $0.85 × 1 × CBRS ending price.
2024 Form S-1 ↗April 2026 Form S-1 and exhibits ↗Final May 2026 prospectus ↗IPO closing announcement ↗Illustrative paper value; no sale or access to a historical investment is assumed. Excludes fees, taxes, cash dividends, warrants and other distributions; fractional shares assumed. The IPO mark does not assume an executable sale.
THE STORY & THE EVIDENCE
Cerebras Systems: before the public market.
Cerebras has a documented preferred-share financing history from Series A through H, followed by its May 2026 IPO. The original issue prices and offering price support a detailed pre-IPO worksheet.
Underwritten IPO10 sourced milestones9 documented share scenarios
- Preferred equity
- Preferred equity
Series B
$25 million$2.754493 per preferred share
Jan 2017. 9,076,079 shares issued.
- Preferred equity
Series C
$65 million$8.9474 per preferred share
Jul & Oct 2017. 7,264,680 shares issued across two months.
- Preferred equity
Series D
$79.8 million$16.1458 per preferred share
Nov 2018–Apr 2019. 4,943,849 shares issued in multiple closings.
- Preferred equity
Series E
$272.1 million$18.3249 per preferred share
Nov 2019–May 2020. 14,848,436 shares issued; a later customer warrant is separate.
- Preferred equity
Series F
$254.4 million$27.7448 per preferred share
Oct–Nov 2021. 9,168,419 shares issued; this filing total is more precise than the rounded $250 million announcement.
- Preferred equity
Series F-1
$85 million$14.66 per preferred share
Jul–Sep 2024. 5,798,089 shares closed. The contemplated G42 primary purchase was not consummated.
- Preferred equity
Series G
About $1.1 billion$36.2324 per preferred share
Sep–Oct 2025. 30,359,557 shares issued in multiple closings.
- Preferred equity
Series H
About $1.0 billion$89.0156 per preferred share
Jan–Feb 2026. 11,394,059 shares issued in multiple closings.
- Underwritten IPO
IPO closes
$6.3825 billion gross$185 offering price
34.5 million Class A shares at $185, including the underwriters’ option: $6.3825 billion gross by arithmetic before expenses.
What the records do not establish
- The Series F-1 financing closed for $85 million; a larger contemplated G42 purchase did not close.
- Round totals, carrying values and company valuations measure different things.
- IPO paper marks do not establish an investor’s allocation, liquidity or realized proceeds.
Research reviewed 2026-09-24. Selected public records, not a complete private cap table. An undisclosed price is left unknown.
Open this company’s sourced data (JSON) ↗
Source documents & filing locations
2024 Form S-1 ↗
Note 10: actual Series A–F issuances, dates and gross proceeds.
April 2026 Form S-1 and exhibits ↗
Certificate of incorporation: Original Issue Price definition, Series A through H; retains full price precision.
Final May 2026 prospectus ↗
Cover: $185 offering price. Preferred-stock note: 1:1 conversion. Related-party financing: F-1, G and H.
IPO closing announcement ↗
May 15, 2026: 34.5 million shares including the underwriters’ option.